市场调查报告书
商品编码
1261252
结肠镜检查全球市场规模、份额、行业趋势分析报告,按应用、最终用户、地区展望和预测,2022-2028 年Global Colonoscope Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Regional Outlook and Forecast, 2022 - 2028 |
在预测期内,结肠镜检查市场规模预计将以 6.8% 的复合年增长率增长,到 2028 年达到 17 亿美元。
此外,预计随着结肠镜治疗能力的提高,结肠镜手术的数量将会增加。 结肠镜检查市场受到越来越多的微创治疗偏好、技术进步和结直肠癌流行的推动。 然而,结直肠癌的病因尚不清楚。 与其他主要地区相比,治疗率的提高、结直肠癌在世界范围内的高患病率以及高昂的药物成本对结直肠癌的主导地位做出了重大贡献。
此外,在结肠镜检查设施中,结肠镜检查的利用率和执行量都很高,这有助于扩大结肠镜检查市场。 有许多增加视角的设备,如结肠镜、短程半径光学系统、结肠镜、具有多个镜头的胃肠设备和各种辅助设备,有助于市场增长。
COVID-19 影响分析
择期手术在大流行期间暂停。 此外,为了限制 COVID-19 感染的风险,结肠镜检查中心已推迟或取消择期和半紧急患者。 因此,这些变量表明结肠镜检查市场在大流行期间受到了适度的不利影响。 然而,广泛的疫苗接种加速了结肠镜检查行业的发展。 近几个月来,一些组织也齐心协力通过宣传活动鼓励癌症筛查,这有望推动未来的市场需求。
市场增长因素
技术进步显着
采用高清结肠镜检查和成像技术升级以更好地显示细微病变和小息肉是结肠镜检查最重要的技术进步之一。 HD 增加了视频显示中的像素数量,使向观众呈现更好、更详细的图像成为可能。 现代结肠镜检查系统可以产生具有 170 度视野的高清 HD 结肠镜检查,提供更明亮的图像、更高的分辨率以及比标准结肠镜检查设备宽 30 度的视野。 考虑到这些因素,结肠镜检查市场预计将在整个预测期内扩大。
越来越偏爱微创手术
结肠镜检查是一种筛查测试,可以检测癌症的早期症状,并通过仅切除少量组织来防止其发展到更危险的阶段。 结肠镜检查是一种诊断程序,其中将小型照相机插入患者的直肠以检查大肠内壁。 该测试快速、无痛且可能挽救生命。 其直接结果是,结肠镜检查市场有望在预测期内扩大。
市场约束
与结肠镜检查相关的高风险
息肉切除术后电凝综合征是一种极为罕见的并发症,涉及肠道损伤。 它还可能导致胃部不适和发烧。 对于 75 岁以上的患者,结肠镜检查出现并发症的风险更高,因为他们更有可能患有基础疾病。 此外,年龄较大的患者可能更难准备手术。 结果,它会导致脱水和电解质失衡。 这些并发症可能会阻止患者接受这些手术,从而阻碍结肠镜检查市场的增长。
应用展望
根据应用,结肠镜检查市场分为结直肠癌、溃疡性结肠炎、克罗恩病等。 到 2021 年,结肠癌细分市场将在结肠镜检查市场中占据最高的收入份额。 年龄、家族史、久坐不动的生活方式、饮酒、吸烟和不健康的生活方式是结直肠癌患者惊人增加的重要因素。 结肠癌是每年男性和女性中第三大最常见的癌症。 预计结直肠癌患病率的增加将导致市场扩张。
最终用户视角
按最终用户划分,结肠镜检查市场分为医院、门诊手术中心等。 2021 年,门诊手术中心部分在结肠镜检查市场中占据了显着的收入份额。 门诊手术中心有望增加其市场份额,因为它们保持功能水平并且不太可能引起免疫反应。 门诊手术中心拥有必要的结肠镜检查设备,因此可以在那里进行手术。 此外,门诊手术设施也有助于扩张,因为它们不需要过夜进行手术。
区域展望
按地区分析了北美、欧洲、亚太地区和 LAMEA 的结肠镜检查市场。 北美地区将在 2021 年以最大的收入份额引领结肠镜检查市场。 这是由于结肠癌和溃疡性结肠炎等慢性病的高发、市场进入者的数量不断增加以及该地区可用设备的种类越来越多。我来了。 此外,该地区研发活动的增加也有助于市场发展。
收购是市场进入者采取的主要策略。 根据发表在 Cardinal Matrix 上的一项分析,Medtronic PLC 在结肠镜检查市场处于领先地位。 Stryker Corporation、Fujifilm Holdings Corporation 和 Olympus Corporation 等公司是结肠镜检查市场的领先创新者。
The Global Colonoscope Market size is expected to reach $1.7 billion by 2028, rising at a market growth of 6.8% CAGR during the forecast period.
The colonoscopy is the primary instrument used in basic colonoscopy. In circumstances where cecal intubation is problematic due to significant colonic stricture and curvature, this instrument has a longer length and diameter than a gastroscope. It includes a control section, an instrument channel with forceps, snare, injector, and clip device, a shaft to be introduced into the patient, the tip, a connecting section, and the line.
Certain variants additionally include a lever for varying stiffness. Colonoscopy requires the use of a colonoscope. It provides superior diagnostic specificity and sensitivity compared to barium enema, stool occult blood test, and computed tomography colonography. Colonoscopy permits accurate diagnosis and treatment without the need for invasive surgery. The increasing incidence of colorectal cancer is a major factor behind expanding the colonoscope market.
Moreover, as the therapeutic capacities of colonoscopes increase, the number of colonoscopy procedures is anticipated to skyrocket. The market for colonoscope is driven by the increasing inclination for minimally invasive treatments, technological advancements, and the prevalence of colorectal cancer. However, it is uncertain what causes colorectal cancer. Increased treatment rates, a high prevalence of colon cancer globally, and elevated drug expenses relative to other major regions are significant contributors to its predominance.
The utilization and amount of colonoscopy procedures performed at these facilities contributed to expanding the colonoscope market. Many instruments that enhance visibility angles, such as colonoscopes, short-run radius optics, colonoscopes, gastrointestinal devices with multiple lenses, and various auxiliary devices, contribute to market growth.
COVID-19 Impact Analysis
During the pandemic, elective surgical procedures were temporarily halted. Furthermore, to limit the danger of COVID-19 transmission, colonoscopy centers have postponed and canceled elective and semi-urgent patients. Hence, these variables indicate that the colonoscope market experienced a moderately negative influence during the pandemic. However, due to widespread vaccination, the colonoscope industry has accelerated. In addition, several organizations have made concerted attempts to encourage cancer screening through awareness campaigns over the past few months, which is anticipated to increase future market demand.
Market Growth Factors
Rising advancements in technologies
The adoption of HD colonoscopes and upgrades in imaging techniques for excellent visibility of subtle lesions and small polyps are among the most significant technological developments in the colonoscopy. HD has increased the number of pixels on the video display, allowing for greater detail and a superior image for the spectator. Modern colonoscopy systems are able to create high-resolution, HD colonoscopes with an angle of view of 170 degrees, providing brighter images, higher resolution, and a field of vision 30 degrees broader than standard colonoscopy instruments. In light of all these factors, the colonoscope market is predicted to expand throughout the forecast period.
Growing preference for minimally invasive procedures
The colonoscopy is a screening procedure that requires only a tiny portion of tissue removal and can detect any early signs of cancer, preventing it from progressing to a more dangerous stage. Colonoscopies are diagnostic procedures that include inspecting the lining of the large intestine by inserting a tiny camera into the rectum of the patient. The process takes only a short amount of time and is completely painless, and it has the potential to save the patient's life. As a direct consequence of this, the market for colonoscope is expected to expand during the time of the projection.
Market Restraining Factors
High risks involved during the colonoscopy procedures
Post-polypectomy electrocoagulation syndrome is an extremely unusual complication involving bowel damage. It might lead to stomach discomfort and fever. Due to the increased likelihood of underlying health concerns, colonoscopies provide a larger risk of complications for patients over 75. In addition, older patients may have a more difficult time preparing for the operation. It may result in dehydration or electrolyte imbalance. These complications may discourage patients from undergoing these operations, consequently hindering the growth of the colonoscope market.
Application Outlook
Based on application, the colonoscope market is segmented into colorectal cancer, ulcerative colitis, crohns disease and others. In 2021, the colorectal cancer segment held the highest revenue share in the colonoscope market. Age, family history, a sedentary lifestyle, consumption of alcohol, smoking, and unhealthy lifestyle behaviors are important contributors to the alarming increase in colorectal cancer cases. In both men and women, colorectal cancer is the third most prevalent cancer each year. This increased incidence of colorectal cancer is anticipated to expand the market.
End User Outlook
By end user, the colonoscope market is bifurcated into hospitals, ambulatory surgery centers and others. The ambulatory surgery centers segment recorded a remarkable revenue share in the colonoscope market in 2021. While ambulatory surgery centers offer to maintain a level of function and are less likely to provoke an immunological reaction, their market share is projected to expand. The procedure is possible there because ambulatory surgery centers are equipped with the necessary colonoscopy equipment. In addition, ambulatory surgery facilities do not require an overnight stay for procedures, contributing to their expansion.
Regional Outlook
Region wise, the colonoscope market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region led the colonoscope market by generating maximum revenue share in 2021. This is due to the high frequency of chronic diseases such as colon cancer & ulcerative colitis, the increasing number of market participants, and the rise in the variety of available devices in the region. In addition, the increase in research & development activities in the region contributes to expanding the market.
The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Medtronic PLC is the forerunner in the Colonoscope Market. Companies such as Stryker Corporation, Fujifilm Holdings Corporation, Olympus Corporation are some of the key innovators in Colonoscope Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, SonoScape Medical Corp., Daichuan Medical (Shenzhen) Co., Ltd. (EndoFresh), and EndoMed Systems GmbH.
Recent Strategies Deployed in Colonoscope Market
Partnership, Collaboration and Agreement:
Jul-2022: Medtronic PLC entered into a partnership with MathWorks, an Israel-based medical technology company focused on cardiovascular disease. With this partnership, the company aimed to provide creative solutions and technologies from diagnosis to therapy.
Nov-2021: Medtronic PLC is partnering with Amazon.com to deliver pill-sized cameras to patients' doorsteps. For Medtronic, the goal is to offer a wider array of PillCams for 2021-Nov: Medtronic formed a partnership with Amazon, an American company that focuses on online advertising, e-commerce, digital streaming, cloud computing, and artificial intelligence. The partnership is aimed at delivering pillcams for patients in their homes for gastrointestinal care.
Product Launch and Product Expansion:
Nov-2021: Fujifilm revealed the ColoAssist PRO visualization system for colonoscopies. The new product allows clinicians to visualize the configuration of the endoscope throughout the procedure in real time by providing accurate navigation of the colonoscope inside the patient. The ColoAssist PRO reproduces a graphical model of the endoscope during the intubation.
Apr-2021: FUJIFILM Medical Systems U.S.A., Inc. unveiled G-EYE 700 Series Colonoscope. The new product would assist with visualization, stabilization, and control during routine examinations that would improve polyp detection when compared to standard colonoscopy. The launch of the G-EYE 700 Series line would expand the offering of the company's colonoscope portfolio.
Oct-2020: Olympus launched two colonoscopes, the PCF-H190T and the PCF-HQ190 in the market. The new PCF-H190T and the PCF-HQ190 offer extension to the existing capabilities for physicians for diagnosing and treating gastrointestinal tract disorders. Furthermore, the two new devices would improve physicians' access to and visualization of the anatomy.
Sep-2020: Olympus Corporation unveiled ENDO-AID, a platform powered by artificial intelligence (AI). The new AI platform includes the endoscopy application ENDO-AID CADe for the colon. The ENDO-AID provides a real-time display of automatically detected suspicious lesions. With this launch. the company aimed to enhance the standard of endoscopy around the world.
Acquisitions and Mergers:
Dec-2022: Olympus entered into an agreement to acquire Odin Vision, a British cloud-AI endoscopy start-up. The acquisition would enhance the company's capability to offer advanced AI-powered solutions and data-driven insights that can improve clinical and procedural workflows and potentially transform patient care.
Nov-2022: Boston Scientific Corporation signed an agreement to acquire Apollo Endosurgery, Inc, a medical technology company focused on the development of advanced therapeutic endoscopy devices. The acquisition is aimed to enter the endobariatric market and provide strong, continued growth of the company's business.
Aug-2022: Medtronic PLC completed the acquisition of Affera, Inc., a medical technology that delivers to address the cardiac arrhythmia market. Through this acquisition, the company aimed to expand its cardiac ablation portfolio that encompasses a fully integrated diagnostic, focal pulsed field, and radiofrequency ablation solution.
Nov-2020: Stryker Corporation took over Wright Medical Group N.V., a medical device company that focuses on extremities and biologics. The acquisition enables the company to enhance its market position globally in the trauma and extremities field. Additionally, the company aimed to grow the business of both companies by providing solutions that improve patient outcomes.
Aug-2020: Olympus Corporation came into an agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V. The acquisition showcases the company's commitment for developing advanced colonoscopy tools and its offering in gastrointestinal therapeutic devices. Moreover, with this acquisition, the company aimed to improve the early detection and treatment of colorectal cancer (CRC).
Trials and Approvals:
Nov-2021: Medtronic PLC received approval for its PillCam™ Small Bowel 3 system from U.S. Food and Drug Administration for remote endoscopy procedures. PillCam SB3 system combines Medtronic's PillCam technology with Amazon logistics which offers a convenient option for a contactless procedure and helps ensure that patients can access care in a timely manner.
May-2021: EndoFresh received approval from FDA for EndoFresh Disposable Digestive Endoscopy System. The new product features an all-in-one design with a camera system, disposable upper GI endoscope, and disposable colonoscope. The product would enable the company to allow physicians to visualize, diagnose and operate gastrointestinal endoscopy.
Apr-2021: Medtronic PLC received de novo clearance from U.S. Food and Drug Administration for its GI Genius™ intelligent endoscopy module. The GI Genius module uses artificial intelligence (AI) to identify colorectal polyps. With the addition of AI in the GI Genius intelligent endoscopy module, the launch is aimed at improving colonoscopies and polyp detection and reducing variability in patient outcomes.
Market Segments covered in the Report:
By Application
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures